nodes	percent_of_prediction	percent_of_DWPC	metapath
Perindopril—ABCB1—lung cancer	0.258	1	CbGaD
Perindopril—BCHE—Irinotecan—lung cancer	0.0759	0.177	CbGbCtD
Perindopril—BCHE—Cisplatin—lung cancer	0.0619	0.145	CbGbCtD
Perindopril—ABCB1—Topotecan—lung cancer	0.0395	0.0922	CbGbCtD
Perindopril—ABCB1—Gefitinib—lung cancer	0.0361	0.0843	CbGbCtD
Perindopril—ABCB1—Vinorelbine—lung cancer	0.0278	0.0649	CbGbCtD
Perindopril—ABCB1—Crizotinib—lung cancer	0.0221	0.0517	CbGbCtD
Perindopril—ABCB1—Gemcitabine—lung cancer	0.0216	0.0505	CbGbCtD
Perindopril—ABCB1—Erlotinib—lung cancer	0.0213	0.0498	CbGbCtD
Perindopril—ABCB1—Paclitaxel—lung cancer	0.0195	0.0456	CbGbCtD
Perindopril—ABCB1—Irinotecan—lung cancer	0.0193	0.045	CbGbCtD
Perindopril—ABCB1—Vinblastine—lung cancer	0.0171	0.04	CbGbCtD
Perindopril—ABCB1—Cisplatin—lung cancer	0.0157	0.0367	CbGbCtD
Perindopril—ABCB1—Etoposide—lung cancer	0.0154	0.036	CbGbCtD
Perindopril—ABCB1—Docetaxel—lung cancer	0.0141	0.033	CbGbCtD
Perindopril—BCHE—diaphragm—lung cancer	0.0114	0.21	CbGeAlD
Perindopril—ABCB1—Doxorubicin—lung cancer	0.0105	0.0246	CbGbCtD
Perindopril—ACE—pulmonary artery—lung cancer	0.0104	0.193	CbGeAlD
Perindopril—ABCB1—Methotrexate—lung cancer	0.0102	0.0238	CbGbCtD
Perindopril—ACE—umbilical vein—lung cancer	0.00689	0.128	CbGeAlD
Perindopril—SLC15A2—mammary gland—lung cancer	0.0023	0.0425	CbGeAlD
Perindopril—SLC15A1—epithelium—lung cancer	0.00205	0.0379	CbGeAlD
Perindopril—ACE—respiratory system—lung cancer	0.00176	0.0325	CbGeAlD
Perindopril—SLC15A2—respiratory system—lung cancer	0.00153	0.0283	CbGeAlD
Perindopril—ACE—epithelium—lung cancer	0.00147	0.0272	CbGeAlD
Perindopril—BCHE—respiratory system—lung cancer	0.0013	0.024	CbGeAlD
Perindopril—SLC15A2—bronchus—lung cancer	0.00126	0.0233	CbGeAlD
Perindopril—ACE—cardiac atrium—lung cancer	0.00122	0.0226	CbGeAlD
Perindopril—SLC15A2—trachea—lung cancer	0.00113	0.0209	CbGeAlD
Perindopril—BCHE—bronchus—lung cancer	0.00107	0.0198	CbGeAlD
Perindopril—ACE—bone marrow—lung cancer	0.00103	0.0191	CbGeAlD
Perindopril—BCHE—trachea—lung cancer	0.000958	0.0177	CbGeAlD
Perindopril—ACE—lung—lung cancer	0.000932	0.0173	CbGeAlD
Perindopril—BCHE—cardiac atrium—lung cancer	0.0009	0.0167	CbGeAlD
Perindopril—SLC15A2—lung—lung cancer	0.000813	0.0151	CbGeAlD
Perindopril—BCHE—bone marrow—lung cancer	0.00076	0.0141	CbGeAlD
Perindopril—BCHE—lung—lung cancer	0.000688	0.0127	CbGeAlD
Perindopril—ACE—lymph node—lung cancer	0.000637	0.0118	CbGeAlD
Perindopril—ABCB1—respiratory system—lung cancer	0.000618	0.0114	CbGeAlD
Perindopril—SLC15A2—lymph node—lung cancer	0.000556	0.0103	CbGeAlD
Perindopril—ABCB1—epithelium—lung cancer	0.000516	0.00956	CbGeAlD
Perindopril—BCHE—lymph node—lung cancer	0.000471	0.00872	CbGeAlD
Perindopril—ABCB1—trachea—lung cancer	0.000457	0.00846	CbGeAlD
Perindopril—ABCB1—bone marrow—lung cancer	0.000362	0.00671	CbGeAlD
Perindopril—ABCB1—lung—lung cancer	0.000328	0.00608	CbGeAlD
Perindopril—ABCB1—lymph node—lung cancer	0.000224	0.00416	CbGeAlD
Perindopril—Upper respiratory tract infection—Doxorubicin—lung cancer	8.32e-05	0.000347	CcSEcCtD
Perindopril—Haemoglobin—Methotrexate—lung cancer	8.31e-05	0.000347	CcSEcCtD
Perindopril—Gastrointestinal disorder—Paclitaxel—lung cancer	8.3e-05	0.000347	CcSEcCtD
Perindopril—Fatigue—Paclitaxel—lung cancer	8.29e-05	0.000346	CcSEcCtD
Perindopril—Haemorrhage—Methotrexate—lung cancer	8.27e-05	0.000345	CcSEcCtD
Perindopril—Hepatitis—Methotrexate—lung cancer	8.27e-05	0.000345	CcSEcCtD
Perindopril—Pollakiuria—Doxorubicin—lung cancer	8.27e-05	0.000345	CcSEcCtD
Perindopril—Asthenia—Gemcitabine—lung cancer	8.24e-05	0.000344	CcSEcCtD
Perindopril—Pain—Paclitaxel—lung cancer	8.23e-05	0.000343	CcSEcCtD
Perindopril—Constipation—Paclitaxel—lung cancer	8.23e-05	0.000343	CcSEcCtD
Perindopril—Confusional state—Docetaxel—lung cancer	8.22e-05	0.000343	CcSEcCtD
Perindopril—Pharyngitis—Methotrexate—lung cancer	8.21e-05	0.000343	CcSEcCtD
Perindopril—Urinary tract disorder—Methotrexate—lung cancer	8.17e-05	0.000341	CcSEcCtD
Perindopril—Photosensitivity reaction—Doxorubicin—lung cancer	8.17e-05	0.000341	CcSEcCtD
Perindopril—Anaphylactic shock—Docetaxel—lung cancer	8.15e-05	0.00034	CcSEcCtD
Perindopril—Oedema—Docetaxel—lung cancer	8.15e-05	0.00034	CcSEcCtD
Perindopril—Pruritus—Gemcitabine—lung cancer	8.13e-05	0.000339	CcSEcCtD
Perindopril—Urethral disorder—Methotrexate—lung cancer	8.11e-05	0.000339	CcSEcCtD
Perindopril—Feeling abnormal—Etoposide—lung cancer	8.08e-05	0.000338	CcSEcCtD
Perindopril—Diarrhoea—Irinotecan—lung cancer	8.07e-05	0.000337	CcSEcCtD
Perindopril—Pneumonia—Doxorubicin—lung cancer	8.02e-05	0.000335	CcSEcCtD
Perindopril—Gastrointestinal pain—Etoposide—lung cancer	8.02e-05	0.000335	CcSEcCtD
Perindopril—Shock—Docetaxel—lung cancer	8.02e-05	0.000335	CcSEcCtD
Perindopril—Nervous system disorder—Docetaxel—lung cancer	8e-05	0.000334	CcSEcCtD
Perindopril—Thrombocytopenia—Docetaxel—lung cancer	7.98e-05	0.000333	CcSEcCtD
Perindopril—Drowsiness—Doxorubicin—lung cancer	7.98e-05	0.000333	CcSEcCtD
Perindopril—Visual impairment—Methotrexate—lung cancer	7.97e-05	0.000333	CcSEcCtD
Perindopril—Tachycardia—Docetaxel—lung cancer	7.96e-05	0.000332	CcSEcCtD
Perindopril—Feeling abnormal—Paclitaxel—lung cancer	7.93e-05	0.000331	CcSEcCtD
Perindopril—Skin disorder—Docetaxel—lung cancer	7.92e-05	0.000331	CcSEcCtD
Perindopril—Stevens-Johnson syndrome—Doxorubicin—lung cancer	7.91e-05	0.00033	CcSEcCtD
Perindopril—Gastrointestinal pain—Paclitaxel—lung cancer	7.87e-05	0.000328	CcSEcCtD
Perindopril—Diarrhoea—Gemcitabine—lung cancer	7.86e-05	0.000328	CcSEcCtD
Perindopril—Renal failure—Doxorubicin—lung cancer	7.84e-05	0.000327	CcSEcCtD
Perindopril—Erythema multiforme—Methotrexate—lung cancer	7.82e-05	0.000327	CcSEcCtD
Perindopril—Dizziness—Irinotecan—lung cancer	7.8e-05	0.000326	CcSEcCtD
Perindopril—Urticaria—Etoposide—lung cancer	7.79e-05	0.000325	CcSEcCtD
Perindopril—Stomatitis—Doxorubicin—lung cancer	7.78e-05	0.000325	CcSEcCtD
Perindopril—Jaundice—Doxorubicin—lung cancer	7.78e-05	0.000325	CcSEcCtD
Perindopril—Anorexia—Docetaxel—lung cancer	7.77e-05	0.000325	CcSEcCtD
Perindopril—Body temperature increased—Etoposide—lung cancer	7.75e-05	0.000324	CcSEcCtD
Perindopril—Abdominal pain—Etoposide—lung cancer	7.75e-05	0.000324	CcSEcCtD
Perindopril—Urinary tract infection—Doxorubicin—lung cancer	7.75e-05	0.000324	CcSEcCtD
Perindopril—Conjunctivitis—Doxorubicin—lung cancer	7.75e-05	0.000324	CcSEcCtD
Perindopril—Eye disorder—Methotrexate—lung cancer	7.73e-05	0.000323	CcSEcCtD
Perindopril—Tinnitus—Methotrexate—lung cancer	7.71e-05	0.000322	CcSEcCtD
Perindopril—Asthenia—Cisplatin—lung cancer	7.68e-05	0.000321	CcSEcCtD
Perindopril—Cardiac disorder—Methotrexate—lung cancer	7.68e-05	0.000321	CcSEcCtD
Perindopril—Sweating—Doxorubicin—lung cancer	7.65e-05	0.000319	CcSEcCtD
Perindopril—Urticaria—Paclitaxel—lung cancer	7.64e-05	0.000319	CcSEcCtD
Perindopril—Hypotension—Docetaxel—lung cancer	7.62e-05	0.000318	CcSEcCtD
Perindopril—Haematuria—Doxorubicin—lung cancer	7.61e-05	0.000318	CcSEcCtD
Perindopril—Body temperature increased—Paclitaxel—lung cancer	7.6e-05	0.000318	CcSEcCtD
Perindopril—Abdominal pain—Paclitaxel—lung cancer	7.6e-05	0.000318	CcSEcCtD
Perindopril—Hepatobiliary disease—Doxorubicin—lung cancer	7.54e-05	0.000315	CcSEcCtD
Perindopril—Epistaxis—Doxorubicin—lung cancer	7.52e-05	0.000314	CcSEcCtD
Perindopril—Angiopathy—Methotrexate—lung cancer	7.5e-05	0.000313	CcSEcCtD
Perindopril—Vomiting—Irinotecan—lung cancer	7.5e-05	0.000313	CcSEcCtD
Perindopril—Sinusitis—Doxorubicin—lung cancer	7.48e-05	0.000313	CcSEcCtD
Perindopril—Mediastinal disorder—Methotrexate—lung cancer	7.45e-05	0.000311	CcSEcCtD
Perindopril—Agranulocytosis—Doxorubicin—lung cancer	7.44e-05	0.000311	CcSEcCtD
Perindopril—Rash—Irinotecan—lung cancer	7.44e-05	0.000311	CcSEcCtD
Perindopril—Dermatitis—Irinotecan—lung cancer	7.43e-05	0.00031	CcSEcCtD
Perindopril—Musculoskeletal discomfort—Docetaxel—lung cancer	7.43e-05	0.00031	CcSEcCtD
Perindopril—Chills—Methotrexate—lung cancer	7.42e-05	0.00031	CcSEcCtD
Perindopril—Headache—Irinotecan—lung cancer	7.39e-05	0.000309	CcSEcCtD
Perindopril—Insomnia—Docetaxel—lung cancer	7.37e-05	0.000308	CcSEcCtD
Perindopril—Diarrhoea—Cisplatin—lung cancer	7.33e-05	0.000306	CcSEcCtD
Perindopril—Paraesthesia—Docetaxel—lung cancer	7.32e-05	0.000306	CcSEcCtD
Perindopril—Alopecia—Methotrexate—lung cancer	7.31e-05	0.000305	CcSEcCtD
Perindopril—Vomiting—Gemcitabine—lung cancer	7.3e-05	0.000305	CcSEcCtD
Perindopril—Bradycardia—Doxorubicin—lung cancer	7.29e-05	0.000304	CcSEcCtD
Perindopril—Dyspnoea—Docetaxel—lung cancer	7.27e-05	0.000304	CcSEcCtD
Perindopril—Somnolence—Docetaxel—lung cancer	7.25e-05	0.000303	CcSEcCtD
Perindopril—Mental disorder—Methotrexate—lung cancer	7.25e-05	0.000303	CcSEcCtD
Perindopril—Rash—Gemcitabine—lung cancer	7.24e-05	0.000302	CcSEcCtD
Perindopril—Dermatitis—Gemcitabine—lung cancer	7.24e-05	0.000302	CcSEcCtD
Perindopril—Malnutrition—Methotrexate—lung cancer	7.2e-05	0.000301	CcSEcCtD
Perindopril—Erythema—Methotrexate—lung cancer	7.2e-05	0.000301	CcSEcCtD
Perindopril—Haemoglobin—Doxorubicin—lung cancer	7.2e-05	0.000301	CcSEcCtD
Perindopril—Headache—Gemcitabine—lung cancer	7.2e-05	0.000301	CcSEcCtD
Perindopril—Rhinitis—Doxorubicin—lung cancer	7.18e-05	0.0003	CcSEcCtD
Perindopril—Dyspepsia—Docetaxel—lung cancer	7.18e-05	0.0003	CcSEcCtD
Perindopril—Haemorrhage—Doxorubicin—lung cancer	7.16e-05	0.000299	CcSEcCtD
Perindopril—Hepatitis—Doxorubicin—lung cancer	7.16e-05	0.000299	CcSEcCtD
Perindopril—Pharyngitis—Doxorubicin—lung cancer	7.11e-05	0.000297	CcSEcCtD
Perindopril—Decreased appetite—Docetaxel—lung cancer	7.09e-05	0.000296	CcSEcCtD
Perindopril—Urinary tract disorder—Doxorubicin—lung cancer	7.07e-05	0.000295	CcSEcCtD
Perindopril—Oedema peripheral—Doxorubicin—lung cancer	7.05e-05	0.000295	CcSEcCtD
Perindopril—Dysgeusia—Methotrexate—lung cancer	7.05e-05	0.000294	CcSEcCtD
Perindopril—Gastrointestinal disorder—Docetaxel—lung cancer	7.04e-05	0.000294	CcSEcCtD
Perindopril—Asthenia—Etoposide—lung cancer	7.04e-05	0.000294	CcSEcCtD
Perindopril—Fatigue—Docetaxel—lung cancer	7.03e-05	0.000294	CcSEcCtD
Perindopril—Urethral disorder—Doxorubicin—lung cancer	7.02e-05	0.000293	CcSEcCtD
Perindopril—Nausea—Irinotecan—lung cancer	7.01e-05	0.000293	CcSEcCtD
Perindopril—ACE—Metabolism of proteins—LMNA—lung cancer	6.98e-05	0.0034	CbGpPWpGaD
Perindopril—Constipation—Docetaxel—lung cancer	6.97e-05	0.000291	CcSEcCtD
Perindopril—Pain—Docetaxel—lung cancer	6.97e-05	0.000291	CcSEcCtD
Perindopril—Back pain—Methotrexate—lung cancer	6.96e-05	0.000291	CcSEcCtD
Perindopril—Pruritus—Etoposide—lung cancer	6.94e-05	0.00029	CcSEcCtD
Perindopril—Visual impairment—Doxorubicin—lung cancer	6.9e-05	0.000288	CcSEcCtD
Perindopril—Asthenia—Paclitaxel—lung cancer	6.9e-05	0.000288	CcSEcCtD
Perindopril—BCHE—Neuronal System—GNG11—lung cancer	6.86e-05	0.00334	CbGpPWpGaD
Perindopril—BCHE—Peptide hormone metabolism—POMC—lung cancer	6.84e-05	0.00333	CbGpPWpGaD
Perindopril—Nausea—Gemcitabine—lung cancer	6.82e-05	0.000285	CcSEcCtD
Perindopril—Vomiting—Cisplatin—lung cancer	6.81e-05	0.000284	CcSEcCtD
Perindopril—Pruritus—Paclitaxel—lung cancer	6.8e-05	0.000284	CcSEcCtD
Perindopril—Erythema multiforme—Doxorubicin—lung cancer	6.77e-05	0.000283	CcSEcCtD
Perindopril—Rash—Cisplatin—lung cancer	6.75e-05	0.000282	CcSEcCtD
Perindopril—Dermatitis—Cisplatin—lung cancer	6.75e-05	0.000282	CcSEcCtD
Perindopril—Feeling abnormal—Docetaxel—lung cancer	6.72e-05	0.000281	CcSEcCtD
Perindopril—Diarrhoea—Etoposide—lung cancer	6.71e-05	0.00028	CcSEcCtD
Perindopril—Eye disorder—Doxorubicin—lung cancer	6.69e-05	0.000279	CcSEcCtD
Perindopril—Ill-defined disorder—Methotrexate—lung cancer	6.68e-05	0.000279	CcSEcCtD
Perindopril—Tinnitus—Doxorubicin—lung cancer	6.68e-05	0.000279	CcSEcCtD
Perindopril—Gastrointestinal pain—Docetaxel—lung cancer	6.67e-05	0.000278	CcSEcCtD
Perindopril—Anaemia—Methotrexate—lung cancer	6.65e-05	0.000278	CcSEcCtD
Perindopril—Flushing—Doxorubicin—lung cancer	6.65e-05	0.000278	CcSEcCtD
Perindopril—Cardiac disorder—Doxorubicin—lung cancer	6.65e-05	0.000278	CcSEcCtD
Perindopril—Diarrhoea—Paclitaxel—lung cancer	6.58e-05	0.000275	CcSEcCtD
Perindopril—SLC15A2—SLC-mediated transmembrane transport—AVP—lung cancer	6.54e-05	0.00319	CbGpPWpGaD
Perindopril—Angiopathy—Doxorubicin—lung cancer	6.5e-05	0.000271	CcSEcCtD
Perindopril—Malaise—Methotrexate—lung cancer	6.49e-05	0.000271	CcSEcCtD
Perindopril—Dizziness—Etoposide—lung cancer	6.49e-05	0.000271	CcSEcCtD
Perindopril—Vertigo—Methotrexate—lung cancer	6.47e-05	0.00027	CcSEcCtD
Perindopril—Mediastinal disorder—Doxorubicin—lung cancer	6.45e-05	0.00027	CcSEcCtD
Perindopril—Abdominal pain—Docetaxel—lung cancer	6.44e-05	0.000269	CcSEcCtD
Perindopril—Body temperature increased—Docetaxel—lung cancer	6.44e-05	0.000269	CcSEcCtD
Perindopril—Leukopenia—Methotrexate—lung cancer	6.44e-05	0.000269	CcSEcCtD
Perindopril—Chills—Doxorubicin—lung cancer	6.43e-05	0.000268	CcSEcCtD
Perindopril—Arrhythmia—Doxorubicin—lung cancer	6.4e-05	0.000267	CcSEcCtD
Perindopril—Dizziness—Paclitaxel—lung cancer	6.36e-05	0.000266	CcSEcCtD
Perindopril—Nausea—Cisplatin—lung cancer	6.36e-05	0.000266	CcSEcCtD
Perindopril—Alopecia—Doxorubicin—lung cancer	6.33e-05	0.000264	CcSEcCtD
Perindopril—SLC15A2—Transmembrane transport of small molecules—ABCC3—lung cancer	6.33e-05	0.00308	CbGpPWpGaD
Perindopril—Cough—Methotrexate—lung cancer	6.28e-05	0.000262	CcSEcCtD
Perindopril—Mental disorder—Doxorubicin—lung cancer	6.27e-05	0.000262	CcSEcCtD
Perindopril—Vomiting—Etoposide—lung cancer	6.24e-05	0.00026	CcSEcCtD
Perindopril—Malnutrition—Doxorubicin—lung cancer	6.23e-05	0.00026	CcSEcCtD
Perindopril—Erythema—Doxorubicin—lung cancer	6.23e-05	0.00026	CcSEcCtD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—RHEB—lung cancer	6.2e-05	0.00302	CbGpPWpGaD
Perindopril—Rash—Etoposide—lung cancer	6.19e-05	0.000258	CcSEcCtD
Perindopril—Dermatitis—Etoposide—lung cancer	6.18e-05	0.000258	CcSEcCtD
Perindopril—BCHE—Metabolism of proteins—KHSRP—lung cancer	6.17e-05	0.00301	CbGpPWpGaD
Perindopril—BCHE—Neuronal System—ADCY1—lung cancer	6.17e-05	0.00301	CbGpPWpGaD
Perindopril—Headache—Etoposide—lung cancer	6.15e-05	0.000257	CcSEcCtD
Perindopril—Flatulence—Doxorubicin—lung cancer	6.14e-05	0.000257	CcSEcCtD
Perindopril—Chest pain—Methotrexate—lung cancer	6.13e-05	0.000256	CcSEcCtD
Perindopril—Myalgia—Methotrexate—lung cancer	6.13e-05	0.000256	CcSEcCtD
Perindopril—Arthralgia—Methotrexate—lung cancer	6.13e-05	0.000256	CcSEcCtD
Perindopril—Tension—Doxorubicin—lung cancer	6.12e-05	0.000255	CcSEcCtD
Perindopril—Vomiting—Paclitaxel—lung cancer	6.12e-05	0.000255	CcSEcCtD
Perindopril—Dysgeusia—Doxorubicin—lung cancer	6.11e-05	0.000255	CcSEcCtD
Perindopril—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	6.09e-05	0.000254	CcSEcCtD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—MTMR3—lung cancer	6.07e-05	0.00296	CbGpPWpGaD
Perindopril—SLC15A1—SLC-mediated transmembrane transport—AVP—lung cancer	6.07e-05	0.00296	CbGpPWpGaD
Perindopril—Rash—Paclitaxel—lung cancer	6.06e-05	0.000253	CcSEcCtD
Perindopril—Dermatitis—Paclitaxel—lung cancer	6.06e-05	0.000253	CcSEcCtD
Perindopril—Discomfort—Methotrexate—lung cancer	6.06e-05	0.000253	CcSEcCtD
Perindopril—Nervousness—Doxorubicin—lung cancer	6.05e-05	0.000253	CcSEcCtD
Perindopril—Back pain—Doxorubicin—lung cancer	6.03e-05	0.000252	CcSEcCtD
Perindopril—Headache—Paclitaxel—lung cancer	6.03e-05	0.000252	CcSEcCtD
Perindopril—Muscle spasms—Doxorubicin—lung cancer	5.99e-05	0.00025	CcSEcCtD
Perindopril—BCHE—Metabolism of proteins—KIF5B—lung cancer	5.94e-05	0.00289	CbGpPWpGaD
Perindopril—Confusional state—Methotrexate—lung cancer	5.92e-05	0.000247	CcSEcCtD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—NODAL—lung cancer	5.88e-05	0.00287	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—lung cancer	5.88e-05	0.00287	CbGpPWpGaD
Perindopril—Anaphylactic shock—Methotrexate—lung cancer	5.88e-05	0.000245	CcSEcCtD
Perindopril—SLC15A1—Transmembrane transport of small molecules—ABCC3—lung cancer	5.87e-05	0.00286	CbGpPWpGaD
Perindopril—Asthenia—Docetaxel—lung cancer	5.85e-05	0.000244	CcSEcCtD
Perindopril—Nausea—Etoposide—lung cancer	5.83e-05	0.000243	CcSEcCtD
Perindopril—Ill-defined disorder—Doxorubicin—lung cancer	5.78e-05	0.000242	CcSEcCtD
Perindopril—Pruritus—Docetaxel—lung cancer	5.77e-05	0.000241	CcSEcCtD
Perindopril—Nervous system disorder—Methotrexate—lung cancer	5.76e-05	0.000241	CcSEcCtD
Perindopril—Anaemia—Doxorubicin—lung cancer	5.76e-05	0.000241	CcSEcCtD
Perindopril—Thrombocytopenia—Methotrexate—lung cancer	5.75e-05	0.00024	CcSEcCtD
Perindopril—SLC15A2—Transmembrane transport of small molecules—GNG11—lung cancer	5.74e-05	0.0028	CbGpPWpGaD
Perindopril—Agitation—Doxorubicin—lung cancer	5.73e-05	0.000239	CcSEcCtD
Perindopril—Nausea—Paclitaxel—lung cancer	5.71e-05	0.000239	CcSEcCtD
Perindopril—Skin disorder—Methotrexate—lung cancer	5.71e-05	0.000238	CcSEcCtD
Perindopril—Hyperhidrosis—Methotrexate—lung cancer	5.68e-05	0.000237	CcSEcCtD
Perindopril—Malaise—Doxorubicin—lung cancer	5.62e-05	0.000235	CcSEcCtD
Perindopril—Vertigo—Doxorubicin—lung cancer	5.6e-05	0.000234	CcSEcCtD
Perindopril—Anorexia—Methotrexate—lung cancer	5.6e-05	0.000234	CcSEcCtD
Perindopril—Syncope—Doxorubicin—lung cancer	5.59e-05	0.000233	CcSEcCtD
Perindopril—Leukopenia—Doxorubicin—lung cancer	5.58e-05	0.000233	CcSEcCtD
Perindopril—Diarrhoea—Docetaxel—lung cancer	5.58e-05	0.000233	CcSEcCtD
Perindopril—Palpitations—Doxorubicin—lung cancer	5.51e-05	0.00023	CcSEcCtD
Perindopril—Hypotension—Methotrexate—lung cancer	5.49e-05	0.000229	CcSEcCtD
Perindopril—Loss of consciousness—Doxorubicin—lung cancer	5.48e-05	0.000229	CcSEcCtD
Perindopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—lung cancer	5.44e-05	0.00265	CbGpPWpGaD
Perindopril—Cough—Doxorubicin—lung cancer	5.44e-05	0.000227	CcSEcCtD
Perindopril—BCHE—Metabolism of proteins—EIF2B5—lung cancer	5.39e-05	0.00263	CbGpPWpGaD
Perindopril—Dizziness—Docetaxel—lung cancer	5.39e-05	0.000225	CcSEcCtD
Perindopril—Hypertension—Doxorubicin—lung cancer	5.38e-05	0.000225	CcSEcCtD
Perindopril—Musculoskeletal discomfort—Methotrexate—lung cancer	5.35e-05	0.000224	CcSEcCtD
Perindopril—SLC15A1—Transmembrane transport of small molecules—GNG11—lung cancer	5.32e-05	0.00259	CbGpPWpGaD
Perindopril—Insomnia—Methotrexate—lung cancer	5.31e-05	0.000222	CcSEcCtD
Perindopril—Myalgia—Doxorubicin—lung cancer	5.31e-05	0.000222	CcSEcCtD
Perindopril—Arthralgia—Doxorubicin—lung cancer	5.31e-05	0.000222	CcSEcCtD
Perindopril—Chest pain—Doxorubicin—lung cancer	5.31e-05	0.000222	CcSEcCtD
Perindopril—Anxiety—Doxorubicin—lung cancer	5.29e-05	0.000221	CcSEcCtD
Perindopril—Paraesthesia—Methotrexate—lung cancer	5.28e-05	0.00022	CcSEcCtD
Perindopril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	5.27e-05	0.00022	CcSEcCtD
Perindopril—Discomfort—Doxorubicin—lung cancer	5.24e-05	0.000219	CcSEcCtD
Perindopril—Dyspnoea—Methotrexate—lung cancer	5.24e-05	0.000219	CcSEcCtD
Perindopril—Somnolence—Methotrexate—lung cancer	5.22e-05	0.000218	CcSEcCtD
Perindopril—Dry mouth—Doxorubicin—lung cancer	5.19e-05	0.000217	CcSEcCtD
Perindopril—Vomiting—Docetaxel—lung cancer	5.18e-05	0.000216	CcSEcCtD
Perindopril—Dyspepsia—Methotrexate—lung cancer	5.17e-05	0.000216	CcSEcCtD
Perindopril—SLC15A2—Transmembrane transport of small molecules—ABCG2—lung cancer	5.16e-05	0.00251	CbGpPWpGaD
Perindopril—SLC15A2—Transmembrane transport of small molecules—ADCY1—lung cancer	5.16e-05	0.00251	CbGpPWpGaD
Perindopril—Rash—Docetaxel—lung cancer	5.14e-05	0.000215	CcSEcCtD
Perindopril—Dermatitis—Docetaxel—lung cancer	5.14e-05	0.000214	CcSEcCtD
Perindopril—Confusional state—Doxorubicin—lung cancer	5.13e-05	0.000214	CcSEcCtD
Perindopril—Decreased appetite—Methotrexate—lung cancer	5.11e-05	0.000213	CcSEcCtD
Perindopril—Headache—Docetaxel—lung cancer	5.11e-05	0.000213	CcSEcCtD
Perindopril—ABCB1—HIF-1-alpha transcription factor network—TERT—lung cancer	5.09e-05	0.00248	CbGpPWpGaD
Perindopril—Anaphylactic shock—Doxorubicin—lung cancer	5.09e-05	0.000212	CcSEcCtD
Perindopril—Oedema—Doxorubicin—lung cancer	5.09e-05	0.000212	CcSEcCtD
Perindopril—Gastrointestinal disorder—Methotrexate—lung cancer	5.07e-05	0.000212	CcSEcCtD
Perindopril—Fatigue—Methotrexate—lung cancer	5.07e-05	0.000212	CcSEcCtD
Perindopril—Pain—Methotrexate—lung cancer	5.02e-05	0.00021	CcSEcCtD
Perindopril—Shock—Doxorubicin—lung cancer	5.01e-05	0.000209	CcSEcCtD
Perindopril—ABCB1—Allograft Rejection—IL10—lung cancer	5e-05	0.00244	CbGpPWpGaD
Perindopril—Nervous system disorder—Doxorubicin—lung cancer	4.99e-05	0.000208	CcSEcCtD
Perindopril—Thrombocytopenia—Doxorubicin—lung cancer	4.98e-05	0.000208	CcSEcCtD
Perindopril—Tachycardia—Doxorubicin—lung cancer	4.97e-05	0.000207	CcSEcCtD
Perindopril—Skin disorder—Doxorubicin—lung cancer	4.94e-05	0.000206	CcSEcCtD
Perindopril—Hyperhidrosis—Doxorubicin—lung cancer	4.92e-05	0.000205	CcSEcCtD
Perindopril—BCHE—Phospholipid metabolism—PIK3CG—lung cancer	4.87e-05	0.00237	CbGpPWpGaD
Perindopril—ABCB1—HIF-1-alpha transcription factor network—HIF1A—lung cancer	4.87e-05	0.00237	CbGpPWpGaD
Perindopril—Anorexia—Doxorubicin—lung cancer	4.85e-05	0.000203	CcSEcCtD
Perindopril—Nausea—Docetaxel—lung cancer	4.84e-05	0.000202	CcSEcCtD
Perindopril—Feeling abnormal—Methotrexate—lung cancer	4.84e-05	0.000202	CcSEcCtD
Perindopril—Gastrointestinal pain—Methotrexate—lung cancer	4.8e-05	0.000201	CcSEcCtD
Perindopril—SLC15A2—Transmembrane transport of small molecules—TF—lung cancer	4.79e-05	0.00234	CbGpPWpGaD
Perindopril—SLC15A1—Transmembrane transport of small molecules—ABCG2—lung cancer	4.79e-05	0.00233	CbGpPWpGaD
Perindopril—SLC15A1—Transmembrane transport of small molecules—ADCY1—lung cancer	4.79e-05	0.00233	CbGpPWpGaD
Perindopril—Hypotension—Doxorubicin—lung cancer	4.75e-05	0.000199	CcSEcCtD
Perindopril—Urticaria—Methotrexate—lung cancer	4.67e-05	0.000195	CcSEcCtD
Perindopril—ABCB1—Allograft Rejection—FASLG—lung cancer	4.65e-05	0.00227	CbGpPWpGaD
Perindopril—Body temperature increased—Methotrexate—lung cancer	4.65e-05	0.000194	CcSEcCtD
Perindopril—Abdominal pain—Methotrexate—lung cancer	4.65e-05	0.000194	CcSEcCtD
Perindopril—Musculoskeletal discomfort—Doxorubicin—lung cancer	4.64e-05	0.000194	CcSEcCtD
Perindopril—Insomnia—Doxorubicin—lung cancer	4.6e-05	0.000192	CcSEcCtD
Perindopril—BCHE—Metabolism—AZIN2—lung cancer	4.59e-05	0.00224	CbGpPWpGaD
Perindopril—BCHE—Metabolism—COL4A3BP—lung cancer	4.59e-05	0.00224	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—ST3GAL5—lung cancer	4.59e-05	0.00224	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—lung cancer	4.57e-05	0.00223	CbGpPWpGaD
Perindopril—Paraesthesia—Doxorubicin—lung cancer	4.57e-05	0.000191	CcSEcCtD
Perindopril—Dyspnoea—Doxorubicin—lung cancer	4.54e-05	0.000189	CcSEcCtD
Perindopril—Somnolence—Doxorubicin—lung cancer	4.52e-05	0.000189	CcSEcCtD
Perindopril—Dyspepsia—Doxorubicin—lung cancer	4.48e-05	0.000187	CcSEcCtD
Perindopril—SLC15A1—Transmembrane transport of small molecules—TF—lung cancer	4.45e-05	0.00217	CbGpPWpGaD
Perindopril—Decreased appetite—Doxorubicin—lung cancer	4.42e-05	0.000185	CcSEcCtD
Perindopril—Gastrointestinal disorder—Doxorubicin—lung cancer	4.39e-05	0.000183	CcSEcCtD
Perindopril—Fatigue—Doxorubicin—lung cancer	4.39e-05	0.000183	CcSEcCtD
Perindopril—ABCB1—Transmembrane transport of small molecules—SLC34A2—lung cancer	4.37e-05	0.00213	CbGpPWpGaD
Perindopril—Constipation—Doxorubicin—lung cancer	4.35e-05	0.000182	CcSEcCtD
Perindopril—Pain—Doxorubicin—lung cancer	4.35e-05	0.000182	CcSEcCtD
Perindopril—BCHE—Phospholipid metabolism—PIK3CD—lung cancer	4.28e-05	0.00209	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	4.28e-05	0.00209	CbGpPWpGaD
Perindopril—Asthenia—Methotrexate—lung cancer	4.22e-05	0.000176	CcSEcCtD
Perindopril—Feeling abnormal—Doxorubicin—lung cancer	4.19e-05	0.000175	CcSEcCtD
Perindopril—Gastrointestinal pain—Doxorubicin—lung cancer	4.16e-05	0.000174	CcSEcCtD
Perindopril—Pruritus—Methotrexate—lung cancer	4.16e-05	0.000174	CcSEcCtD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	4.14e-05	0.00202	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—ADAMTS1—lung cancer	4.09e-05	0.00199	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—B4GALT5—lung cancer	4.09e-05	0.00199	CbGpPWpGaD
Perindopril—Urticaria—Doxorubicin—lung cancer	4.04e-05	0.000169	CcSEcCtD
Perindopril—Abdominal pain—Doxorubicin—lung cancer	4.02e-05	0.000168	CcSEcCtD
Perindopril—Body temperature increased—Doxorubicin—lung cancer	4.02e-05	0.000168	CcSEcCtD
Perindopril—Diarrhoea—Methotrexate—lung cancer	4.02e-05	0.000168	CcSEcCtD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—lung cancer	4e-05	0.00195	CbGpPWpGaD
Perindopril—ABCB1—HIF-1-alpha transcription factor network—CREBBP—lung cancer	3.98e-05	0.00194	CbGpPWpGaD
Perindopril—SLC15A2—SLC-mediated transmembrane transport—ALB—lung cancer	3.96e-05	0.00193	CbGpPWpGaD
Perindopril—BCHE—Metabolism—ATP5H—lung cancer	3.9e-05	0.0019	CbGpPWpGaD
Perindopril—Dizziness—Methotrexate—lung cancer	3.89e-05	0.000162	CcSEcCtD
Perindopril—ACE—Metabolism of proteins—MMP1—lung cancer	3.87e-05	0.00189	CbGpPWpGaD
Perindopril—Vomiting—Methotrexate—lung cancer	3.74e-05	0.000156	CcSEcCtD
Perindopril—BCHE—Phospholipid metabolism—PIK3CB—lung cancer	3.73e-05	0.00182	CbGpPWpGaD
Perindopril—Rash—Methotrexate—lung cancer	3.7e-05	0.000155	CcSEcCtD
Perindopril—Dermatitis—Methotrexate—lung cancer	3.7e-05	0.000155	CcSEcCtD
Perindopril—Headache—Methotrexate—lung cancer	3.68e-05	0.000154	CcSEcCtD
Perindopril—SLC15A1—SLC-mediated transmembrane transport—ALB—lung cancer	3.68e-05	0.00179	CbGpPWpGaD
Perindopril—Asthenia—Doxorubicin—lung cancer	3.65e-05	0.000152	CcSEcCtD
Perindopril—Pruritus—Doxorubicin—lung cancer	3.6e-05	0.00015	CcSEcCtD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	3.59e-05	0.00175	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—GRP—lung cancer	3.58e-05	0.00174	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—lung cancer	3.56e-05	0.00174	CbGpPWpGaD
Perindopril—Nausea—Methotrexate—lung cancer	3.49e-05	0.000146	CcSEcCtD
Perindopril—Diarrhoea—Doxorubicin—lung cancer	3.48e-05	0.000145	CcSEcCtD
Perindopril—BCHE—Metabolism—PLBD1—lung cancer	3.48e-05	0.00169	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—CASP8—lung cancer	3.46e-05	0.00169	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	3.42e-05	0.00167	CbGpPWpGaD
Perindopril—BCHE—Transmission across Chemical Synapses—BRAF—lung cancer	3.4e-05	0.00166	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—APP—lung cancer	3.38e-05	0.00165	CbGpPWpGaD
Perindopril—Dizziness—Doxorubicin—lung cancer	3.36e-05	0.000141	CcSEcCtD
Perindopril—SLC15A2—Transmembrane transport of small molecules—AVP—lung cancer	3.32e-05	0.00162	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—SLC22A18—lung cancer	3.31e-05	0.00161	CbGpPWpGaD
Perindopril—Vomiting—Doxorubicin—lung cancer	3.24e-05	0.000135	CcSEcCtD
Perindopril—BCHE—Phospholipid metabolism—PTEN—lung cancer	3.23e-05	0.00157	CbGpPWpGaD
Perindopril—SLC15A2—Transmembrane transport of small molecules—ABCB1—lung cancer	3.22e-05	0.00157	CbGpPWpGaD
Perindopril—ACE—Metabolism of proteins—POMC—lung cancer	3.22e-05	0.00157	CbGpPWpGaD
Perindopril—Rash—Doxorubicin—lung cancer	3.21e-05	0.000134	CcSEcCtD
Perindopril—Dermatitis—Doxorubicin—lung cancer	3.21e-05	0.000134	CcSEcCtD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—lung cancer	3.2e-05	0.00156	CbGpPWpGaD
Perindopril—Headache—Doxorubicin—lung cancer	3.19e-05	0.000133	CcSEcCtD
Perindopril—BCHE—Metabolism—HSD17B10—lung cancer	3.18e-05	0.00155	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—ATF3—lung cancer	3.12e-05	0.00152	CbGpPWpGaD
Perindopril—SLC15A1—Transmembrane transport of small molecules—AVP—lung cancer	3.08e-05	0.0015	CbGpPWpGaD
Perindopril—Nausea—Doxorubicin—lung cancer	3.02e-05	0.000126	CcSEcCtD
Perindopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—lung cancer	3e-05	0.00146	CbGpPWpGaD
Perindopril—ACE—Metabolism of proteins—MMP2—lung cancer	2.99e-05	0.00146	CbGpPWpGaD
Perindopril—SLC15A1—Transmembrane transport of small molecules—ABCB1—lung cancer	2.99e-05	0.00146	CbGpPWpGaD
Perindopril—BCHE—Metabolism—CKB—lung cancer	2.96e-05	0.00144	CbGpPWpGaD
Perindopril—ABCB1—HIF-1-alpha transcription factor network—JUN—lung cancer	2.94e-05	0.00143	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—lung cancer	2.9e-05	0.00142	CbGpPWpGaD
Perindopril—BCHE—Transmission across Chemical Synapses—MDM2—lung cancer	2.85e-05	0.00139	CbGpPWpGaD
Perindopril—BCHE—Transmission across Chemical Synapses—RAF1—lung cancer	2.84e-05	0.00139	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—LMNA—lung cancer	2.8e-05	0.00137	CbGpPWpGaD
Perindopril—BCHE—Metabolism—GSTM2—lung cancer	2.78e-05	0.00135	CbGpPWpGaD
Perindopril—BCHE—Metabolism—CNDP2—lung cancer	2.78e-05	0.00135	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—CXCL8—lung cancer	2.74e-05	0.00133	CbGpPWpGaD
Perindopril—ABCB1—HIF-1-alpha transcription factor network—EP300—lung cancer	2.71e-05	0.00132	CbGpPWpGaD
Perindopril—BCHE—Metabolism—MTMR3—lung cancer	2.7e-05	0.00132	CbGpPWpGaD
Perindopril—BCHE—Metabolism—PGAM1—lung cancer	2.64e-05	0.00128	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—CASP3—lung cancer	2.62e-05	0.00128	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—IL2—lung cancer	2.61e-05	0.00127	CbGpPWpGaD
Perindopril—BCHE—Neuronal System—BRAF—lung cancer	2.61e-05	0.00127	CbGpPWpGaD
Perindopril—ABCB1—HIF-1-alpha transcription factor network—VEGFA—lung cancer	2.57e-05	0.00125	CbGpPWpGaD
Perindopril—SLC15A2—Transmembrane transport of small molecules—APOA1—lung cancer	2.54e-05	0.00124	CbGpPWpGaD
Perindopril—BCHE—Metabolism—CYP2A7—lung cancer	2.51e-05	0.00123	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—lung cancer	2.5e-05	0.00122	CbGpPWpGaD
Perindopril—ACE—Metabolism of proteins—CXCL8—lung cancer	2.49e-05	0.00121	CbGpPWpGaD
Perindopril—BCHE—Metabolism—SDC4—lung cancer	2.46e-05	0.0012	CbGpPWpGaD
Perindopril—SLC15A1—Transmembrane transport of small molecules—APOA1—lung cancer	2.36e-05	0.00115	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—lung cancer	2.3e-05	0.00112	CbGpPWpGaD
Perindopril—BCHE—Phospholipid metabolism—PIK3CA—lung cancer	2.28e-05	0.00111	CbGpPWpGaD
Perindopril—BCHE—Metabolism—GSTA3—lung cancer	2.24e-05	0.00109	CbGpPWpGaD
Perindopril—BCHE—Metabolism—RRM1—lung cancer	2.24e-05	0.00109	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—COL4A3BP—lung cancer	2.24e-05	0.00109	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—AZIN2—lung cancer	2.24e-05	0.00109	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—VEGFA—lung cancer	2.22e-05	0.00108	CbGpPWpGaD
Perindopril—BCHE—Neuronal System—MDM2—lung cancer	2.19e-05	0.00107	CbGpPWpGaD
Perindopril—BCHE—Neuronal System—RAF1—lung cancer	2.18e-05	0.00106	CbGpPWpGaD
Perindopril—SLC15A2—Transmembrane transport of small molecules—CREBBP—lung cancer	2.15e-05	0.00105	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—lung cancer	2.11e-05	0.00103	CbGpPWpGaD
Perindopril—BCHE—Metabolism—B4GALT5—lung cancer	2.11e-05	0.00103	CbGpPWpGaD
Perindopril—BCHE—Metabolism—GSTA4—lung cancer	2.05e-05	0.000999	CbGpPWpGaD
Perindopril—SLC15A2—Transmembrane transport of small molecules—ALB—lung cancer	2.01e-05	0.000981	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	2e-05	0.000976	CbGpPWpGaD
Perindopril—BCHE—Metabolism—GSTA2—lung cancer	2e-05	0.000973	CbGpPWpGaD
Perindopril—SLC15A1—Transmembrane transport of small molecules—CREBBP—lung cancer	2e-05	0.000973	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—ABCC3—lung cancer	1.99e-05	0.000967	CbGpPWpGaD
Perindopril—BCHE—Metabolism—GSTA1—lung cancer	1.93e-05	0.000939	CbGpPWpGaD
Perindopril—BCHE—Metabolism—ABCC3—lung cancer	1.91e-05	0.000929	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—ATP5H—lung cancer	1.9e-05	0.000928	CbGpPWpGaD
Perindopril—SLC15A1—Transmembrane transport of small molecules—ALB—lung cancer	1.87e-05	0.000911	CbGpPWpGaD
Perindopril—BCHE—Metabolism—AKR1C1—lung cancer	1.85e-05	0.000899	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—APC—lung cancer	1.83e-05	0.000893	CbGpPWpGaD
Perindopril—SLC15A2—Transmembrane transport of small molecules—RAF1—lung cancer	1.82e-05	0.000887	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—lung cancer	1.81e-05	0.000883	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—GNG11—lung cancer	1.8e-05	0.000877	CbGpPWpGaD
Perindopril—BCHE—Metabolism—UGT1A1—lung cancer	1.79e-05	0.000873	CbGpPWpGaD
Perindopril—BCHE—Metabolism—GNG11—lung cancer	1.73e-05	0.000842	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.72e-05	0.000838	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—lung cancer	1.71e-05	0.000832	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—lung cancer	1.7e-05	0.000828	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—PLBD1—lung cancer	1.7e-05	0.000827	CbGpPWpGaD
Perindopril—SLC15A1—Transmembrane transport of small molecules—RAF1—lung cancer	1.69e-05	0.000824	CbGpPWpGaD
Perindopril—BCHE—Metabolism—ALDOA—lung cancer	1.64e-05	0.000802	CbGpPWpGaD
Perindopril—ABCB1—HIF-1-alpha transcription factor network—AKT1—lung cancer	1.64e-05	0.000798	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—lung cancer	1.62e-05	0.000791	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—ADCY1—lung cancer	1.62e-05	0.000789	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—ABCG2—lung cancer	1.62e-05	0.000789	CbGpPWpGaD
Perindopril—BCHE—Metabolism—NCOA3—lung cancer	1.6e-05	0.000778	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.57e-05	0.000765	CbGpPWpGaD
Perindopril—BCHE—Transmission across Chemical Synapses—HRAS—lung cancer	1.57e-05	0.000763	CbGpPWpGaD
Perindopril—BCHE—Metabolism—ADCY1—lung cancer	1.55e-05	0.000757	CbGpPWpGaD
Perindopril—BCHE—Metabolism—ABCG2—lung cancer	1.55e-05	0.000757	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—MMP1—lung cancer	1.55e-05	0.000757	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—HSD17B10—lung cancer	1.55e-05	0.000756	CbGpPWpGaD
Perindopril—BCHE—Metabolism—ENO2—lung cancer	1.52e-05	0.000742	CbGpPWpGaD
Perindopril—BCHE—Metabolism—HPGDS—lung cancer	1.52e-05	0.000742	CbGpPWpGaD
Perindopril—BCHE—Metabolism—PPP2R1B—lung cancer	1.51e-05	0.000738	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—TF—lung cancer	1.5e-05	0.000733	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.49e-05	0.000728	CbGpPWpGaD
Perindopril—BCHE—Metabolism—GSTT1—lung cancer	1.48e-05	0.00072	CbGpPWpGaD
Perindopril—BCHE—Metabolism—GCLC—lung cancer	1.46e-05	0.000712	CbGpPWpGaD
Perindopril—BCHE—Metabolism—CYP2A6—lung cancer	1.46e-05	0.000712	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.45e-05	0.000709	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—lung cancer	1.44e-05	0.000704	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—CKB—lung cancer	1.44e-05	0.000703	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—lung cancer	1.44e-05	0.000701	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—lung cancer	1.42e-05	0.000694	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—lung cancer	1.39e-05	0.000678	CbGpPWpGaD
Perindopril—BCHE—Metabolism—ENO1—lung cancer	1.38e-05	0.000675	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.38e-05	0.000672	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.36e-05	0.000664	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—GSTM2—lung cancer	1.36e-05	0.000661	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—CNDP2—lung cancer	1.36e-05	0.000661	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—MTMR3—lung cancer	1.32e-05	0.000643	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	1.29e-05	0.00063	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—POMC—lung cancer	1.29e-05	0.000629	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—PGAM1—lung cancer	1.29e-05	0.000627	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	1.26e-05	0.000613	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	1.26e-05	0.000612	CbGpPWpGaD
Perindopril—BCHE—Metabolism—CYP2E1—lung cancer	1.24e-05	0.000605	CbGpPWpGaD
Perindopril—BCHE—Metabolism—NQO1—lung cancer	1.23e-05	0.000598	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—CYP2A7—lung cancer	1.23e-05	0.000598	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	1.22e-05	0.000593	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	1.21e-05	0.000592	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.2e-05	0.000586	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—MMP2—lung cancer	1.2e-05	0.000585	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—SDC4—lung cancer	1.2e-05	0.000585	CbGpPWpGaD
Perindopril—BCHE—Neuronal System—HRAS—lung cancer	1.2e-05	0.000584	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.19e-05	0.000581	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	1.16e-05	0.000564	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	1.13e-05	0.000549	CbGpPWpGaD
Perindopril—BCHE—Metabolism—STK11—lung cancer	1.11e-05	0.000539	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	1.1e-05	0.000534	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—RRM1—lung cancer	1.09e-05	0.000533	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—GSTA3—lung cancer	1.09e-05	0.000533	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—AVP—lung cancer	1.04e-05	0.000508	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.04e-05	0.000506	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	1.04e-05	0.000505	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—B4GALT5—lung cancer	1.03e-05	0.000501	CbGpPWpGaD
Perindopril—BCHE—Metabolism—GSTP1—lung cancer	1.02e-05	0.000499	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	1.01e-05	0.000492	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—GSTA4—lung cancer	1e-05	0.000487	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—CXCL8—lung cancer	9.98e-06	0.000487	CbGpPWpGaD
Perindopril—BCHE—Metabolism—CAT—lung cancer	9.97e-06	0.000486	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—EP300—lung cancer	9.91e-06	0.000483	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	9.87e-06	0.000481	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—GSTA2—lung cancer	9.75e-06	0.000475	CbGpPWpGaD
Perindopril—BCHE—Metabolism—ABCB1—lung cancer	9.69e-06	0.000472	CbGpPWpGaD
Perindopril—BCHE—Metabolism—TYMS—lung cancer	9.52e-06	0.000464	CbGpPWpGaD
Perindopril—BCHE—Metabolism—GSTM1—lung cancer	9.41e-06	0.000459	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—GSTA1—lung cancer	9.4e-06	0.000458	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	9.32e-06	0.000454	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—ABCC3—lung cancer	9.3e-06	0.000453	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—AKR1C1—lung cancer	9e-06	0.000439	CbGpPWpGaD
Perindopril—BCHE—Metabolism—CYP1A1—lung cancer	8.92e-06	0.000435	CbGpPWpGaD
Perindopril—BCHE—Metabolism—ERCC2—lung cancer	8.85e-06	0.000431	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—UGT1A1—lung cancer	8.74e-06	0.000426	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	8.56e-06	0.000417	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—GNG11—lung cancer	8.43e-06	0.000411	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	8.29e-06	0.000404	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—ALDOA—lung cancer	8.03e-06	0.000391	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—APOA1—lung cancer	7.97e-06	0.000389	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—NCOA3—lung cancer	7.79e-06	0.00038	CbGpPWpGaD
Perindopril—BCHE—Metabolism—APOA1—lung cancer	7.65e-06	0.000373	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—ABCG2—lung cancer	7.58e-06	0.000369	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—ADCY1—lung cancer	7.58e-06	0.000369	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—HPGDS—lung cancer	7.43e-06	0.000362	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—ENO2—lung cancer	7.43e-06	0.000362	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—PPP2R1B—lung cancer	7.39e-06	0.00036	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	7.33e-06	0.000357	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—GSTT1—lung cancer	7.21e-06	0.000351	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—CYP2A6—lung cancer	7.13e-06	0.000347	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—GCLC—lung cancer	7.13e-06	0.000347	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	7e-06	0.000341	CbGpPWpGaD
Perindopril—BCHE—Metabolism—PIK3CG—lung cancer	6.99e-06	0.000341	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—ENO1—lung cancer	6.76e-06	0.000329	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	6.75e-06	0.000329	CbGpPWpGaD
Perindopril—BCHE—Metabolism—POMC—lung cancer	6.65e-06	0.000324	CbGpPWpGaD
Perindopril—BCHE—Metabolism—CREBBP—lung cancer	6.48e-06	0.000316	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	6.32e-06	0.000308	CbGpPWpGaD
Perindopril—BCHE—Metabolism—PIK3CD—lung cancer	6.14e-06	0.000299	CbGpPWpGaD
Perindopril—BCHE—Metabolism—ALB—lung cancer	6.06e-06	0.000296	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—CYP2E1—lung cancer	6.06e-06	0.000295	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—NQO1—lung cancer	5.99e-06	0.000292	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	5.71e-06	0.000278	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—STK11—lung cancer	5.4e-06	0.000263	CbGpPWpGaD
Perindopril—BCHE—Metabolism—PIK3CB—lung cancer	5.35e-06	0.000261	CbGpPWpGaD
Perindopril—BCHE—Metabolism—PTGS2—lung cancer	5.31e-06	0.000259	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—GSTP1—lung cancer	5e-06	0.000244	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—CAT—lung cancer	4.86e-06	0.000237	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—TYMS—lung cancer	4.65e-06	0.000226	CbGpPWpGaD
Perindopril—BCHE—Metabolism—PTEN—lung cancer	4.63e-06	0.000225	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—GSTM1—lung cancer	4.59e-06	0.000224	CbGpPWpGaD
Perindopril—BCHE—Metabolism—EP300—lung cancer	4.41e-06	0.000215	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—CYP1A1—lung cancer	4.35e-06	0.000212	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—ERCC2—lung cancer	4.32e-06	0.00021	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—APOA1—lung cancer	3.73e-06	0.000182	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—PIK3CG—lung cancer	3.41e-06	0.000166	CbGpPWpGaD
Perindopril—BCHE—Metabolism—PIK3CA—lung cancer	3.26e-06	0.000159	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—POMC—lung cancer	3.25e-06	0.000158	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—CREBBP—lung cancer	3.16e-06	0.000154	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—PIK3CD—lung cancer	3e-06	0.000146	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—ALB—lung cancer	2.96e-06	0.000144	CbGpPWpGaD
Perindopril—BCHE—Metabolism—AKT1—lung cancer	2.67e-06	0.00013	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—PIK3CB—lung cancer	2.61e-06	0.000127	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—PTGS2—lung cancer	2.59e-06	0.000126	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—PTEN—lung cancer	2.26e-06	0.00011	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—EP300—lung cancer	2.15e-06	0.000105	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—PIK3CA—lung cancer	1.59e-06	7.76e-05	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—AKT1—lung cancer	1.3e-06	6.34e-05	CbGpPWpGaD
